These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 227502)
41. Production of the alpha-subunit of glycoprotein hormones by pituitary adenomas. Landolt AM; Heitz PU; Zenklusen HR Pathol Res Pract; 1988 Sep; 183(5):610-2. PubMed ID: 2467270 [TBL] [Abstract][Full Text] [Related]
42. The role of octreotide (Sandostatin) in non-growth hormone-, non-thyroid-stimulating hormone-, and non-prolactin-secreting adenomas. Warnet A Metabolism; 1992 Sep; 41(9 Suppl 2):59-61. PubMed ID: 1325596 [TBL] [Abstract][Full Text] [Related]
43. The efficacy of conventional radiation therapy in the management of pituitary adenoma. Sasaki R; Murakami M; Okamoto Y; Kono K; Yoden E; Nakajima T; Nabeshima S; Kuroda Y Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1337-45. PubMed ID: 10889388 [TBL] [Abstract][Full Text] [Related]
44. Results of neurosurgical treatment by a transsphenoidal approach in 10 patients with Nelson's syndrome. Wisławski J; Kasperlik-Załuska AA; Jeske W; Migdalska B; Janik J; Załuska J; Bonicki W J Neurosurg; 1985 Jan; 62(1):68-71. PubMed ID: 2981103 [TBL] [Abstract][Full Text] [Related]
45. [Secretion of growth hormone and ACTH in pituitary tumors]. Materazzi F; Rolla M; Tronchetti F Ann Endocrinol (Paris); 1972; 33(4):344-52. PubMed ID: 4351893 [No Abstract] [Full Text] [Related]
51. [Morphology of the paraadenomatous adenohypophysis. A contribution to the pathogenesis of pituitary adenomas (author's transl)]. Saeger W Virchows Arch A Pathol Anat Histol; 1977 Jan; 372(4):299-314. PubMed ID: 139015 [TBL] [Abstract][Full Text] [Related]
52. Chromophobe adenomas of the pituitary gland in Cushing's disease. Lindholm J; Rasmussen P; Korsgaard O Acta Endocrinol (Copenh); 1969 Dec; 62(4):647-52. PubMed ID: 4311983 [No Abstract] [Full Text] [Related]
54. Alpha particles versus conventional radiotherapy to the pituitary region: a comparison of risk-benefit. Linfoot JA Clin Neurosurg; 1980; 27():83-98. PubMed ID: 7023785 [No Abstract] [Full Text] [Related]
55. Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours. Grattan-Smith PJ; Morris JG; Langlands AO J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):949-55. PubMed ID: 1431959 [TBL] [Abstract][Full Text] [Related]
56. Possible role of a radiation-induced p53 mutation in a Nelson's syndrome patient with a fatal outcome. Pinto EM; Siqueira SA; Cukier P; Fragoso MC; Lin CJ; de Mendonca BB Pituitary; 2011 Dec; 14(4):400-4. PubMed ID: 19655257 [TBL] [Abstract][Full Text] [Related]
57. Stereotactic irradiation for pituitary disease. Thorén M; Sääf M; Degerblad M; Rähn T; Norén G; Bergstrand CG; Tallstedt L; Backlund EO Horm Res; 1988; 30(2-3):101-3. PubMed ID: 2854818 [No Abstract] [Full Text] [Related]
58. Does pituitary radiotherapy increase the risk of stroke and, if so, what preventative actions should be taken? Ayuk J Clin Endocrinol (Oxf); 2012 Mar; 76(3):328-31. PubMed ID: 22107606 [TBL] [Abstract][Full Text] [Related]
59. Nelson's syndrome and behavioural changes reversed by selective adenomectomy. Buckler HM; Freeman H; Chetty MC; Anderson DC Br J Psychiatry; 1988 Mar; 152():412-4. PubMed ID: 2844352 [TBL] [Abstract][Full Text] [Related]
60. Intracranial dissemination of pituitary adenoma. Case report and review of the literature. Giordana MT; Cavalla P; Allegranza A; Pollo B Ital J Neurol Sci; 1994 May; 15(4):195-200. PubMed ID: 7960673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]